Brett Andrew King, MD, PhD, FAAD

Moderator | 19th Annual SOCS Scientific Symposium

Dr. King is professor of dermatology at Yale School of Medicine, specializing in inflammatory skin diseases. He has pioneered the use of Janus kinase (JAK) inhibitors in dermatology, and his work has revealed the broad utility of JAK inhibitors for the treatment of alopecia areata, vitiligo, atopic dermatitis, granulomatous disorders, and other conditions.

Membership

Learn benefits & Join us!

Resource Library

Videos, Links & Blog Articles

Partnership

Become a partner today!
Newsletter Icon

Research Award

Click here for more information on the Valeant Research Award.

Learn More
>

Curtis Icon

Cutis Journal

Read published peer-reviewed articles written your by Skin of Color Society members

Newsletter Icon

Join Our Newsletter

Stay up-to-date on the latest news and happenings related to The Skin of Color Society.

Did you know Icon

Did You Know

Skin of color patients comprise the majority in California, New Mexico and Texas…and soon will be the majority in Arizona, Nevada, Georgia, New York and Florida.

By 2042, more than 50% of the US population will have skin of color.